Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,820 | 56 | 99.0% |
| Education | $18.28 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $565.48 | 15 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $229.90 | 8 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $167.77 | 2 | $0 (2024) |
| GENZYME CORPORATION | $157.17 | 5 | $0 (2024) |
| Ziehm Imaging, Inc. | $137.43 | 2 | $0 (2017) |
| Inari Medical, Inc. | $107.18 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $86.63 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $72.18 | 5 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $51.92 | 4 | $0 (2023) |
| Edwards Lifesciences Corporation | $41.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $668.33 | 28 | AstraZeneca Pharmaceuticals LP ($167.77) |
| 2023 | $660.32 | 15 | Actelion Pharmaceuticals US, Inc. ($279.40) |
| 2022 | $107.01 | 8 | Bayer HealthCare Pharmaceuticals Inc. ($57.95) |
| 2021 | $41.92 | 1 | Edwards Lifesciences Corporation ($41.92) |
| 2019 | $222.88 | 3 | Actelion Pharmaceuticals US, Inc. ($152.06) |
| 2017 | $137.43 | 2 | Ziehm Imaging, Inc. ($137.43) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $118.34 | General |
| Category: Immunology | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $113.56 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Cardiology | ||||||
| 11/18/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Immunology | ||||||
| 10/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: Immunology | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $54.21 | General |
| Category: Respiratory | ||||||
| 09/27/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Cardiology | ||||||
| 09/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $2.96 | General |
| Category: Immunology | ||||||
| 09/12/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.58 | General |
| Category: Immunology | ||||||
| 08/22/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 08/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/16/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Cardiology | ||||||
| 08/14/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: Medical Device | ||||||
| 06/25/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: RESPIRATORY | ||||||
| 05/22/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Cardiology | ||||||
| 05/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: RESPIRATORY | ||||||
| 05/17/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Cardiology | ||||||
| 04/24/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $19.08 | General |
| Category: Medical Device | ||||||
| 04/19/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Cardiology | ||||||
| 03/15/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Cardiology | ||||||
| 03/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 320 | 402 | $133,953 | $50,620 |
| 2022 | 5 | 191 | 240 | $66,662 | $26,003 |
| 2021 | 6 | 228 | 303 | $88,491 | $32,127 |
| 2020 | 12 | 354 | 530 | $128,362 | $44,742 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 108 | 164 | $75,932 | $28,363 | 37.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 41 | $17,302 | $5,866 | 33.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 44 | $9,592 | $4,285 | 44.7% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 31 | 39 | $9,087 | $3,468 | 38.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 47 | $7,144 | $2,967 | 41.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 22 | $6,336 | $2,277 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 18 | $5,058 | $1,952 | 38.6% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 13 | 13 | $2,340 | $902.98 | 38.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 14 | 14 | $1,162 | $537.55 | 46.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 52 | 74 | $34,558 | $13,528 | 39.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 71 | 97 | $14,841 | $5,784 | 39.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 32 | 32 | $9,248 | $3,537 | 38.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 25 | 25 | $5,375 | $2,099 | 39.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 12 | $2,640 | $1,055 | 40.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 64 | 94 | $46,498 | $16,773 | 36.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 49 | 63 | $14,096 | $5,522 | 39.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 61 | 92 | $13,783 | $5,076 | 36.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 28 | 28 | $8,090 | $2,885 | 35.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 15 | 15 | $3,675 | $1,033 | 28.1% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 11 | 11 | $2,349 | $837.46 | 35.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 49 | 112 | $61,824 | $19,677 | 31.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 127 | 226 | $32,996 | $12,798 | 38.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 32 | 35 | $9,590 | $3,752 | 39.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 16 | 21 | $6,048 | $2,223 | 36.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 29 | $6,235 | $2,059 | 33.0% |
About Dr. John Kern, DO
Dr. John Kern, DO is a Internal Medicine healthcare provider based in Pomona, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2012. The National Provider Identifier (NPI) number assigned to this provider is 1588930879.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Kern, DO has received a total of $1,838 in payments from pharmaceutical and medical device companies, with $668.33 received in 2024. These payments were reported across 57 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,820).
As a Medicare-enrolled provider, Kern has provided services to 1,093 Medicare beneficiaries, totaling 1,475 services with total Medicare billing of $153,492. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Pomona, NJ
- Active Since 03/30/2012
- Last Updated 04/12/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1588930879
Products in Payments
- UPTRAVI (Drug) $251.01
- Adempas (Drug) $229.90
- DUPIXENT (Biological) $192.73
- OPSUMIT (Drug) $189.47
- AIRSUPRA (Drug) $113.56
- FLOWTRIEVER CATHETER, S (Device) $107.18
- OFEV (Drug) $86.63
- FASENRA (Biological) $54.21
- LifeVest (Device) $51.92
- TRELEGY ELLIPTA (Drug) $44.01
- HemoSphere (Device) $41.92
- (AK6) Vest Therapy (Device) $35.52
- ARALAST (Biological) $30.78
- NUCALA (Biological) $28.17
- FUROSCIX (Drug) $23.88
- Impella (Device) $22.39
- TYVASO (Drug) $19.53
- LUMRYZ (Drug) $18.96
- (8874) inCourage (Device) $16.94
- VERQUVO (Drug) $16.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pomona
Ewa Konca, Md, MD
Internal Medicine — Payments: $148,575
Dr. Derrick Raptis, M.d, M.D
Internal Medicine — Payments: $45,838
Mehul Sonawala, M.d, M.D
Internal Medicine — Payments: $37,212
Mallu Reddy, Md, MD
Internal Medicine — Payments: $22,153
Ramanna Merla, Md, MD
Internal Medicine — Payments: $19,277
Rita Pradhan, Md, MD
Internal Medicine — Payments: $16,436